Department of Medicine, St, Raphael of St, Francis hospital Nsambya, P.O. BOX 7146, Kampala, Uganda.
BMC Infect Dis. 2013 Mar 5;13:122. doi: 10.1186/1471-2334-13-122.
There is a documented increase of diabetes mellitus in Sub Saharan Africa, a region where tuberculosis is highly endemic. Currently, diabetes mellitus is one of the recognised risk factors of tuberculosis. No study has reported the magnitude of diabetes mellitus among tuberculosis patients in Uganda, one of the countries with a high burden of tuberculosis.
This was a cross-sectional study conducted among 260 consenting adult patients with a confirmed diagnosis of tuberculosis admitted on the pulmonology wards of Mulago national referral and teaching hospital in Kampala, Uganda to determine the prevalence of diabetes mellitus and associated clinical factors. Laboratory findings as well as the socio-demographic and clinical data collected using a validated questionnaire was obtained. Point of care random blood sugar (RBS) testing was performed on all the patients prior to initiation of anti tuberculosis treatment. Diabetes mellitus was diagnosed if the RBS level was ≥ 200mg/dl in the presence of the classical symptoms of diabetes mellitus.
The prevalence of diabetes mellitus among the admitted patients with tuberculosis was 8.5%. Only 5 (1.9%) patients with TB had a known diagnosis of diabetes mellitus at enrolment. Majority of the study participants with TB-DM co-infection had type 2 diabetes mellitus (n=20, 90.9%).At bivariate analysis, raised mean ALT concentrations of ≥80 U/L were associated with DM (OR-6.1, 95% CI 1.4-26.36, p=0.032) and paradoxically, HIV co-infection was protective of DM (OR-0.32, 95% CI 0.13-0.79, P=0.016). The relationship between DM and HIV as well as that with ALT remained statistically significant at multivariate analysis (HIV: OR- 0.17 95%CI 0.06-0.51, p=0.002 and ALT: OR-11.42 95%CI 2.15-60.59, p=0.004).
This study demonstrates that diabetes mellitus is common among hospitalized tuberculosis patients in Uganda. The significant clinical predictors associated with diabetes mellitus among tuberculosis patients were HIV co-infection and raised mean serum alanine transaminase concentrations.
在撒哈拉以南非洲地区,糖尿病的发病率有记录性的增加,该地区也是结核病高度流行的地区。目前,糖尿病是结核病的一个公认的危险因素。在乌干达,有一种结核病负担很重的国家,还没有研究报告结核病患者中糖尿病的患病率。
这是一项在乌干达坎帕拉的穆拉戈国家转诊和教学医院呼吸科病房住院的 260 名经确诊患有结核病的成年患者中进行的横断面研究,旨在确定糖尿病的患病率和相关的临床因素。收集了实验室结果以及使用经过验证的问卷获得的社会人口统计学和临床数据。所有患者在开始抗结核治疗前均进行即时血糖仪(RBS)检测。如果 RBS 水平≥200mg/dl 且存在糖尿病的典型症状,则诊断为糖尿病。
在住院结核病患者中,糖尿病的患病率为 8.5%。仅 5(1.9%)名结核病患者在入组时就已确诊患有糖尿病。大多数患有结核病合并糖尿病的研究参与者患有 2 型糖尿病(n=20,90.9%)。在单变量分析中,丙氨酸氨基转移酶(ALT)浓度升高≥80U/L 与 DM 相关(OR-6.1,95%CI 1.4-26.36,p=0.032),而具有讽刺意味的是,HIV 合并感染对 DM 具有保护作用(OR-0.32,95%CI 0.13-0.79,P=0.016)。在多变量分析中,DM 与 HIV 以及 DM 与 ALT 之间的关系仍然具有统计学意义(HIV:OR-0.17 95%CI 0.06-0.51,p=0.002 和 ALT:OR-11.42 95%CI 2.15-60.59,p=0.004)。
本研究表明,糖尿病在乌干达住院结核病患者中很常见。与结核病患者的糖尿病相关的显著临床预测因素是 HIV 合并感染和升高的血清丙氨酸氨基转移酶浓度。